Targeted Photo-Induced Elimination of Tumor-Associated Macrophages Suppresses Cancer Progression in a Murine Model

Kohei Nakajima1, Tomomi Uchiyama1, Kazuki Funayama1

  • 1Laboratory of Bioanalysis and Molecular Imaging, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, Japan.

Cancer Science
|August 4, 2026
PubMed

Insights

Near-infrared photoimmunotherapy targeting colony-stimulating factor 1 receptor (CSF1R) selectively eliminates tumor-associated macrophages (TAMs). This approach suppresses tumor growth and enhances antitumor immunity without systemic toxicity, offering a promising cancer therapy.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Tumor-associated macrophages (TAMs) create an immunosuppressive tumor microenvironment (TME).
  • Targeting colony-stimulating factor 1 receptor (CSF1R) on TAMs is a therapeutic strategy, but systemic depletion risks off-target toxicity.
  • Developing selective TAM elimination methods is crucial for effective cancer immunotherapy.

Purpose of the Study:

  • To investigate near-infrared photoimmunotherapy (NIR-PIT) for selective TAM elimination.
  • To evaluate the therapeutic efficacy of CSF1R-targeted NIR-PIT in a murine cancer model.
  • To assess the potential of NIR-PIT to remodel the TME and enhance antitumor immunity.

Main Methods:

  • Conjugating an anti-CSF1R antibody fragment (Fab) with a photosensitizer (IRDye 700DX).
  • Administering the conjugate and irradiating with near-infrared (NIR) light in tumor-bearing mice.
  • Analyzing tumor growth, survival, immune cell populations, and histology post-treatment.

Main Results:

  • NIR-PIT with Fab-IR700 significantly suppressed tumor growth and improved survival.
  • Repeated NIR-PIT cycles led to durable anticancer effects, including rejection of reimplanted tumors.
  • Treatment effectively depleted TAMs and altered intra-tumoral immune cell composition without systemic toxicity.

Conclusions:

  • CSF1R-targeted NIR-PIT offers a selective method for eliminating TAMs.
  • This approach can remodel the TME towards an antitumor state.
  • NIR-PIT is a promising strategy to enhance immunotherapy for refractory tumors.